Sign Up to like & get
recommendations!
0
Published in 2020 at "The Lancet Neurology"
DOI: 10.1016/s1474-4422(20)30070-3
Abstract: BACKGROUND Azathioprine is used as a first-line treatment to prevent relapses of neuromyelitis optica spectrum disorder (NMOSD). Tocilizumab has been reported to reduce NMOSD disease activity in retrospective case reports. We aimed to compare the…
read more here.
Keywords:
tocilizumab group;
treatment;
azathioprine group;
azathioprine ... See more keywords